Ensysce Biosciences, Inc. (ENSC) vs Mangoceuticals, Inc. (MGRX)

A side-by-side comparison of Ensysce Biosciences, Inc. and Mangoceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Ensysce Biosciences, Inc. logo
ENSC
Ensysce Biosciences, Inc.
$7M
$0.43HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Mangoceuticals, Inc. logo
MGRX
Mangoceuticals, Inc.
$8M
$0.45HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — ENSC vs MGRX

growth of $100 · dividends reinvested · last 4y
ENSC -99.6% (-74.5%/yr)MGRX -99.3% (-71.1%/yr)MGRX compounded faster over this window
020406080100Start $100202420252026$0$1
ENSC MGRX

ENSC vs MGRX: by the numbers

  • •MGRX is the larger company ($8M vs $7M market cap).
  • •Both run net losses; ENSC's is the smaller (-1084.23% vs -4791.48% net margin).

Metrics side by side

Valuation

MetricENSCMGRX
P/S ratio5.6724.22
P/B ratioN/A0.61

Profitability

MetricENSCMGRX
Gross margin0.00%54.43%
Operating margin0.00%-4200.46%
Net margin-1084.23%-4791.48%
ROEN/A-120.58%
ROICN/A-102.91%

Growth (annualized)

MetricENSCMGRX
Total return CAGR (5Y)-86.22%N/A

Go deeper

Full ENSC analysisFull MGRX analysisInteractive comparison tool

Dig into the metrics

Ensysce Biosciences ROEMangoceuticals ROEEnsysce Biosciences operating marginMangoceuticals operating marginEnsysce Biosciences revenue growthMangoceuticals revenue growthEnsysce Biosciences free cash flowMangoceuticals free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.